Details For Selected Brain Tumor Treatment
Sponsored By
Brain tumor book
Please Click On The Above Banner For More Details
Braintumor Website

Back to New Treatments List Back to New Treatments List

Treatment Name: A Phase I Study of Imatinib Mesylate (Gleevec) in Combination With Temozolomide (Temodar) in Patients With Malignant Glioma
Phase: Phase 1
Treatment ID#: 1804        
Age Group: Adults Only
Min Karnofsky Score: 70: Cares for self, unable to perform normal activity or to do active work
Conditions: Prior Surgery is Allowed
Prior Radiation is Allowed
Prior Chemotherapy is Allowed
Last Updated: 08/20/2007
Tumor Types: Anaplastic Astrocytoma
Glioblastoma Multiforme
Gliosarcoma
Oligodendroglioma High Grade
Comments:
Treatment Type: Chemotherapy
Contact: David Reardon MD
The Brain Tumor Center at Duke
Rm 047 Baker House, Hospital South
Trent Drive
Durham, NC 27710 USA
Phone: (919)684-5301
Fax: (919)684-6674
E-mail: reard003@mc.duke.edu
Website: www.cancer.duke.edu/btc
  • Last updated refers to the date when our listing for each treatment was last updated.
  • ID is a combination of our internal ID and the official ID for the trial, if any.
  • Min Karnofsky is a general guide to how well you have to function to use this treatment


Home | Brain Tumor Guide | Search | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Chat | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us | Doctors Address Book

IF YOU ARE USING A SCREEN READER, CLICK HERE
[Click HERE to open a Printer Friendly Version Of This Page!]

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By
World Wide Websites